Raymond James on Medtronic, Inc. (MDT) Earnings: 'All in, this result and guide fell short of our elevated expectations'

Medtronic, Inc. (mdt) PT Raised to $107 at Evercore ISI

August 19, 2025 4:15 PM EDT

Evercore ISI analyst Vijay Kumar raised the price target on Medtronic, Inc. (NYSE: mdt) to $107.00 (from $106.00) while maintaining a Outperform rating.

The analyst comments "Thesis Update: Im in the EU & thought the Caesars phrase (w some tweaks) was apt in... More

TD Cowen Reiterates Buy Rating on Medtronic, Inc. (MDT)

August 19, 2025 8:32 AM EDT

TD Cowen analyst Joshua Jennings reiterated a Buy rating and $106.00 price target on Medtronic, Inc. (NYSE: MDT).

The analyst comments "MDT reported F1Q'26 adjusted revenue of $8.54B with underlying organic growth of 4.8%. Reported revenue exceeded the $8.38B consensus target,... More

Truist Securities Reiterates Hold Rating on Medtronic, Inc. (MDT)

August 19, 2025 8:30 AM EDT

Truist Securities analyst Richard Newitter reiterated a Hold rating and $92.00 price target on Medtronic, Inc. (NYSE: MDT).

The analyst comments "MDT's 4.8% organic rev growth was roughly in-line with 4.9% CNS, while higher reported rev (on FX) and (+$0.02 non-op items) drove a slight EPS beat ($1.26 vs CNS $1.23) on roughly... More

Goldman on Medtronic, Inc. (MDT), 'believe investors had expected total organic growth acceleration to follow the strong performance in CAS'

August 19, 2025 8:05 AM EDT

Goldman Sachs analyst David Roman reiterated a Sell rating and $78.00 price target on Medtronic, Inc. (NYSE: MDT)

The analyst comments "This morning, Medtronic reported 1QFY26 that on a reported basis exceeded both GSe/Consensus (Visible Alpha consensus Data, unless otherwise noted). On an... More

Stifel Reiterates Hold Rating on Medtronic, Inc. (MDT)

August 19, 2025 8:01 AM EDT

Stifel analyst Rick Wise reiterated a Hold rating and $87.00 price target on Medtronic, Inc. (NYSE: MDT).

The analyst comments "Reporting yet another largely as expected quarter, F1Q26 performance was positively just above Consensus for both organic growth and EPS...and this... More

Mizuho on Medtronic, Inc. (MDT): 'Largely Inline Print Likely Overshadowed by New Board Appointees'

August 19, 2025 7:58 AM EDT

Mizuho analyst Anthony Petrone reiterated an Outperform rating and $100.00 price target on Medtronic, Inc. (NYSE: MDT)

The analyst comments "MDT reported a +$195mn/+$0.03 beat driven by strong performances across Cardiovascular (+$92mn ahead of Street), Diabetes (+22mn ahead of Street) and MedSurg... More

Medtronic appoints two directors, forms board committees after Elliott talks

August 19, 2025 6:47 AM EDT

Medtronic plc (NYSE: MDT) appointed John Groetelaars and Bill Jellison as independent directors to its board, effective immediately, the medical device company announced Monday.

The Dublin-based company also formed two new board committees focused on growth and operations. The Growth Committee will oversee merger and acquisition activities, research and development investments, and potential divestitures, including... More

Medtronic (MDT) Tops Q1 EPS by 3c, Beats on Revenue; Offers FY26 EPS Guidance

August 19, 2025 6:46 AM EDT

Medtronic (NYSE: MDT) reported Q1 EPS of $1.26, $0.03 better than the analyst estimate of $1.23. Revenue for the quarter came in at $8.6 billion versus the consensus estimate of $8.38 billion.

GUIDANCE:

Medtronic sees FY2026 EPS of $5.60-$5.66, versus the consensus of $5.55.

For earnings history and earnings-related data on Medtronic (MDT) click here.

... More

Medtronic adds board members after Elliott becomes major shareholder - report 

August 19, 2025 6:45 AM EDT

Investing.com -- Medtronic PLC (NYSE: MDT) plans to announce the addition of two new independent directors to its board on Tuesday as part of an agreement with activist investor Elliott Investment... More

Medtronic to add two new directors after Elliott takes large stake

August 19, 2025 5:59 AM EDT

By Puyaan Singh and Kamal Choudhury

(Reuters) -Medtronic said on Tuesday it would add two new directors to its board and set up committees to help boost its lagging shares after activist investor Elliott Investment Management emerged as one of its largest shareholders.

The medical-device maker said veteran medtech executives John Groetelaars, once interim CEO for Dentsply Sirona, and Bill Jellison, formerly CFO at Stryker, would join its board as independent directors.

Medtronic also raised its... More

Medtronic (MDT) to add Directors as Elliott becomes major shareholder - WSJ

August 19, 2025 5:57 AM EDT

(Updated - August 19, 2025 6:29 AM EDT)

Medtronic (NYSE: MDT) to add Directors as Elliott becomes major shareholder - WSJ

The company plans to announce the board changes alongside its earnings release later on Tuesday.Medtronic will appoint John Groetelaars and Bill Jellison... More

Medtronic poised for Q1 beat on strong product cycle, currency tailwinds

August 19, 2025 4:00 AM EDT

Medtronic plc will report its fiscal first-quarter 2026 earnings results before the market opens on Tuesday.

Analysts at Needham & Company expects Medtronic to exceed consensus revenue and earnings per share (EPS) estimates, supported by new product launches, solid market growth, favorable currency trends, and what it characterizes as conservative management guidance.

Needham also anticipates that Medtronic will raise its FY26 revenue and EPS outlook, citing the F1Q26 upside, currency tailwinds, and tariff relief.

According to the brokerage, Medtronic is in the early stages of a robust product cycle,... More

Raymond James on Medtronic, Inc. (MDT): 'Expecting a Strong F1Q; Consistency and Margins are Key'

August 18, 2025 7:56 AM EDT

Raymond James analyst Jayson Bedford reiterated a Market Perform rating on Medtronic, Inc. (NYSE: MDT).

The analyst comments "The F1Q setup is intriguing given investor excitement over new product cycles (Affera, RDN) and the YTD move in the stock (+16% YTD vs. +1%... More

Goldman now owns a big slug of this med-tech stock, possibly for an activist

August 15, 2025 3:03 PM EDT

A major med-tech stock showed up on the books of a major brokerage firm in a big way in the second quarter, according to the latest 13F filings and an event-driven analyst who tracked the move.

Goldman Sachs now owns nearly $1.4 billion in Medtronic (NYSE:... More

Needham Reiterates Hold Rating on Medtronic, Inc. (MDT)

August 15, 2025 5:22 AM EDT

Needham analyst Michael Matson reiterated a Hold rating on Medtronic, Inc. (NYSE: MDT).

The analyst comments "Medtronic (MDT - Hold) will report its F1Q26 earnings on Tuesday, 8/19/25 at 6:45 am ET and host its earnings webcast at 8:00 am ET. Inside this... More